4//SEC Filing
Cerulean Pharma Inc. 4
Accession 0001209191-14-065549
$DARECIK 0001401914operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:03 PM ET
Size
5.5 KB
Accession
0001209191-14-065549
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-10-29+50,300→ 242,457 totalExercise: $4.36Exp: 2024-10-28→ Common Stock (50,300 underlying)
Footnotes (1)
- [F1]This option was granted on October 29, 2014. The option vests as to 2.08333% of the underlying shares monthly through and including October 29, 2018.
Documents
Issuer
Cerulean Pharma Inc.
CIK 0001401914
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401914
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:03 PM ET
- Size
- 5.5 KB